Christopher I. Li
Ph.D., University of Washington, Epidemiology, 2002.
M.P.H., University of Washington, Epidemiology, 2000.
M.D., University of California, San Francisco, 2000.
B.S., Stanford University, Biological Sciences, 1995.
My research interests lie principally in the field of breast cancer and understanding factors related to its etiology and outcomes using a multidisciplinary approach. I am actively investigating the relationships between various hormonal exposures and risks of different types of breast cancer based on their morphology and expression of different tumor markers. I am also interested in breast cancer outcomes and am currently leading studies that investigate risk factors for second primary breast cancer among breast cancer survivors. Another part of my work focuses on identifying markers that could be used for the early detection of different cancers using various proteomic platforms. Finally, I have an interest in examining disparities in cancer stage, treatment, and survival by race/ethnicity.
(Reading, Writing, Speaking)
Spanish: (Basic, Basic, Basic)
American Association for Cancer Research
2006-2010, Associate Member, Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Program in Epidemiology
Improving the Quality of Biomarker Discovery Research: The Right Samples and Enough of Them.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 2015.
Insurance status and risk of cancer mortality among adolescents and young adults.. Cancer. 121(8):1279-86.. 2015.
Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 21(7):1764-71.. 2015.
Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy.. Breast cancer research and treatment.. 2014.
Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 2014.
Dermcidin expression is associated with disease progression and survival among breast cancer patients.. Breast cancer research and treatment.. 2014.
The risk of breast cancer associated with specific patterns of migraine history.. Cancer causes & control : CCC. 25(12):1707-15.. 2014.
Recent Oral Contraceptive Use by Formulation and Breast Cancer Risk among Women 20 to 49 Years of Age.. Cancer research. 74(15):4078-89.. 2014.
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status.. Journal of the National Cancer Institute.. 2014.
Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.. Breast cancer research and treatment.. 2014.
Antihypertensive medications and breast cancer risk-reply.. JAMA internal medicine. 174(4):641.. 2014.
Net risk reclassification p values: valid or misleading? Journal of the National Cancer Institute. 106(4):dju041.. 2014.
Obstetric outcomes in young women with breast cancer: prior, concurrent, and subsequent pregnancies. American Journal of Obstetrics and Gynecology. 210:S313-S313.. 2014.
Preeclampsia and Breast Cancer Risk According to Tumor Biology. Reproductive Sciences. 21:285a-285a.. 2014.
Long-Term Statin Use and Risk of Ductal and Lobular Breast Cancer among Women 55 to 74 Years of Age.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(9):1529-37.. 2013.
AACR Cancer Progress Report 2013.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(20 Suppl):S1-S98.. 2013.
Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.. Breast cancer research and treatment. 137(2):579-87.. 2013.
Racial/Ethnic Differences in Use and Duration of Adjuvant Hormonal Therapy for Breast Cancer in the Women's Health Initiative.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 2013.
Evaluation of seasonality in the diagnosis of acute myeloid leukaemia among adults in the United States, 1992-2008.. British journal of haematology. 160(3):343-50.. 2013.
Use of antihypertensive medications and breast cancer risk.. Cancer causes & control : CCC. 24(2):365-71.. 2013.
Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.. Breast cancer research and treatment. 142(3):629-36.. 2013.
Use of Antihypertensive Medications and Breast Cancer Risk Among Women Aged 55 to 74 Years.. JAMA internal medicine.. 2013.
Disparities in Access to Lung Transplantation for Cystic Fibrosis Patients by Socioeconomic Status.. American journal of respiratory and critical care medicine.. 2012.